Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2Phase 2 1

Status

Recruiting 232Active not recruiting 85Completed 76Not yet recruiting 46Enrolling by invitation 18Terminated 12Suspended 9Withdrawn 5Available 2

Sponsor Class

OTHER 5

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Genitourinary 17Lymphoid 16Thoracic 13Other hematologic neoplasm 10Gastrointestinal 10Breast 6Tumor-Agnostic 5Plasma cell 5CNS 5Other solid neoplasm 4Head & Neck 4Dermatologic 4Gynecologic 3Sarcoma 1Myeloid 1Classical hematology 1

Conditions

Neoplasms 5

Interventions

monalizumab 1Immunoconjugates 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Withdrawn × Tumor-Agnostic × 90 days × Clear all
NCT04488224 2026-05-19

Nano-X IG

University of Sydney

Phase EARLY_PHASE1 Withdrawn
Tumor-Agnostic

Neoplasms

NCT05495802 2026-05-15

OOSLOH

University Hospital, Lille

Withdrawn
Tumor-Agnostic

Neoplasms

NCT07052760 2026-04-29

Imaging of Solid Tumors Using DLL3 SPECT

University of California, San Francisco

Phase EARLY_PHASE1 Withdrawn
Tumor-Agnostic

Neoplasms

NCT06152523 2026-04-06

MONAMI

Assistance Publique - Hôpitaux de Paris

Phase 2 Withdrawn
Tumor-Agnostic

Neoplasms

NCT07222358 2026-04-06

Multi-component Remote Assessment in Adult Survivors Using a Connected Technology Platform for Healthcare Delivery

St. Jude Children's Research Hospital

Withdrawn
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡